Abstract
This review article discusses about the current cancer treatment techniques and the extensive recent research studies done on nanoparticles as carrier systems for the delivery of anticancer drug molecules in cancer treatment. A variety of nanoparticles of different structural and chemical formulations have been tested for their target-specificity and as drug carrier systems. Numerous scientific research works have been performed to test the use of magnetic nanoparticles in the treatment of carcinogenic brain tumour cells and breast cancer cells; colloid gold nanoparticles, liposomes and polymeric micelles as drug delivery systems to target tumour cells and deliver anticarcinogenic drug in a controlled manner. The article also discusses about ceramic nanoparticles and its applications in photodynamic therapy for cancer treatment. The article thus reviews the subject in brief with suitable references to original research articles and review articles discussing the earlier and current research findings about various types of nanoparticles as drug delivery systems in cancer therapy.
Keywords: Nanoparticles, drug delivery systems, cancer therapy, magnetic nanoparticles, colloid gold nanoparticles, liposomes, polymeric micelles
Current Nanoscience
Title: Targeting Nanoparticles as Drug Delivery Systems for Cancer Treatment
Volume: 5 Issue: 2
Author(s): Karthikeyan Subramani, Hossein Hosseinkhani, Ameen Khraisat, Mohsen Hosseinkhani and Yashwant Pathak
Affiliation:
Keywords: Nanoparticles, drug delivery systems, cancer therapy, magnetic nanoparticles, colloid gold nanoparticles, liposomes, polymeric micelles
Abstract: This review article discusses about the current cancer treatment techniques and the extensive recent research studies done on nanoparticles as carrier systems for the delivery of anticancer drug molecules in cancer treatment. A variety of nanoparticles of different structural and chemical formulations have been tested for their target-specificity and as drug carrier systems. Numerous scientific research works have been performed to test the use of magnetic nanoparticles in the treatment of carcinogenic brain tumour cells and breast cancer cells; colloid gold nanoparticles, liposomes and polymeric micelles as drug delivery systems to target tumour cells and deliver anticarcinogenic drug in a controlled manner. The article also discusses about ceramic nanoparticles and its applications in photodynamic therapy for cancer treatment. The article thus reviews the subject in brief with suitable references to original research articles and review articles discussing the earlier and current research findings about various types of nanoparticles as drug delivery systems in cancer therapy.
Export Options
About this article
Cite this article as:
Subramani Karthikeyan, Hosseinkhani Hossein, Khraisat Ameen, Hosseinkhani Mohsen and Pathak Yashwant, Targeting Nanoparticles as Drug Delivery Systems for Cancer Treatment, Current Nanoscience 2009; 5(2) . https://dx.doi.org/10.2174/157341309788185406
DOI https://dx.doi.org/10.2174/157341309788185406 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Purinergic Receptors and Pain
Current Pharmaceutical Design Homeostasis and the Importance for a Balance Between AKT/mTOR Activity and Intracellular Signaling
Current Medicinal Chemistry PET Imaging of Beta-Adrenoceptors in Human Brain: A Realistic Goal or a Mirage?
Current Pharmaceutical Design Recent Advances in Receptor-Targeted Fluorescent Probes for In Vivo Cancer Imaging
Current Medicinal Chemistry 1,3,4-Thiadiazole Based Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry PET Tracers for Serotonin Receptors and Their Applications
Central Nervous System Agents in Medicinal Chemistry Novel Action and Mechanism of Auranofin in Inhibition of Vascular Endothelial Growth Factor Receptor-3-Dependent Lymphangiogenesis
Anti-Cancer Agents in Medicinal Chemistry Differentiation of Non-Pharmacological from Pharmacological Dopamine Release in the Living Human Brain
Current Medical Imaging MicroRNAs: The New Challenge for Traumatic Brain Injury Diagnosis
Current Neuropharmacology Phytometabolites Targeting the Warburg Effect in Cancer Cells: A Mechanistic Review
Current Drug Targets From Bone Marrow Transplantation to Cellular Therapies: Possible Therapeutic Strategies in Managing Autoimmune Disorders
Current Pharmaceutical Design Hematopoietic Stem Cells: Transcriptional Regulation, Ex Vivo Expansion and Clinical Application
Current Molecular Medicine Alzheimer’s Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy
Current Pharmaceutical Design Targeting CNS Transporters for Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design Vascular Homing Peptides with Cell-Penetrating Properties
Current Pharmaceutical Design Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry Fibroblast Activation Protein in Remodeling Tissues
Current Molecular Medicine Choice of Treatment with Antidepressants: Influencing Factors
Current Pharmaceutical Design Dietary Additive Probiotics Modulation of the Intestinal Microbiota
Protein & Peptide Letters Synergistic Antiproliferative and Antiangiogenic Effects of EGFR and mTOR Inhibitors
Current Pharmaceutical Design